⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

Dermatitis bullous

6,324 total reports3.6% serious outcomes

6,324

Total Reports

Deaths

223

Hospitalizations

3.6

Severity Rate

% serious outcomes

About Dermatitis bullous Reports

Dermatitis bullous has been reported 6,324 times in VAERS from 1990 to 2026.

Of these reports, 6 were associated with death (0.09%) and 223 involved hospitalization.

The overall serious outcome rate (death or hospitalization) for reports mentioning Dermatitis bullous is 3.6%.

Understanding Dermatitis bullous in VAERS

•Temporal association only: These reports show Dermatitis bullous occurred after vaccination, not necessarily because of vaccination.

•Background rates matter: Many symptoms occur naturally at baseline rates in the population, unrelated to vaccination.

•Reporting variability: Medical terminology may be used differently by various healthcare providers and over time.

•Investigation needed: High-frequency reports may trigger further epidemiological studies to determine causation.

What This Data Shows

Most Associated Vaccines: The vaccines most frequently mentioned in reports with Dermatitis bullous. This may reflect usage patterns, not causation.

Severity Patterns: The percentage of reports that involve serious outcomes can help prioritize safety investigations.

Reporting Trends: Changes in reporting frequency over time may reflect increased awareness, media attention, or actual safety signals.